Brossmer R, Bohn B, Sauer A, zur Hausen H
Eur J Cancer Clin Oncol. 1985 Jul;21(7):825-31. doi: 10.1016/0277-5379(85)90222-6.
Two established cell lines of human B-cell lymphomas derived from Burkitt lymphomas and their Epstein-Barr virus-transformed counterparts were analyzed with respect to their ability to bind the beta-galactoside-specific lectin Ricinus communis agglutinin (RCA). Native and sialidase- as well as sialidase-beta-galactosidase-treated cells were compared. The method for the quantitative determination of average numbers of binding sites and of apparent affinity constants was flow cytometry with fluorescence-labeled lectin. Although with native cells there was no significant deviation of the values for virus-transformed cells from those for the parent cells, some differences could be detected after glycosidase treatment. The general procedure of the combined application of specific glycosidases and the quantitation of sugar-specific lectin binding is recommended as a general strategy for the differentiation of cells with known or putative differences in biological functions.
对两种源自伯基特淋巴瘤的人B细胞淋巴瘤细胞系及其爱泼斯坦-巴尔病毒转化的对应细胞系,就其结合β-半乳糖苷特异性凝集素蓖麻凝集素(RCA)的能力进行了分析。对天然细胞、经唾液酸酶处理的细胞以及经唾液酸酶-半乳糖苷酶处理的细胞进行了比较。采用荧光标记凝集素的流式细胞术来定量测定结合位点的平均数和表观亲和常数。尽管对于天然细胞,病毒转化细胞的值与亲代细胞的值没有显著偏差,但在糖苷酶处理后可检测到一些差异。建议将特异性糖苷酶联合应用及糖特异性凝集素结合定量的一般程序作为区分具有已知或推测生物学功能差异的细胞的一般策略。